Omnia SanaPlant Comparison
Blue gum eucalyptus vs Heartsease
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Blue gum eucalyptus and Heartsease: they share 6 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Blue gum eucalyptus | Heartsease | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 2/10 | Comparable evidence |
| Cold & flu | 2/10 | 2/10 | Comparable evidence |
| Immune support | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 3/10 | Comparable evidence |
| Respiratory support | 2/10 | 1/10 | Comparable evidence |
| Skin irritation | 2/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Leaf essential oil dominated by 1,8-cineole (eucalyptol, typically 70%+), the principal compound responsible for the plant's antimicrobial, anti-inflammatory and expectorant/decongestant activity.
Bioactive cyclic peptides shown to suppress over-active immune (T-cell) responses - the rationale for use in inflammatory skin disease; the cytotoxic cyclotides vitri A, varv A and varv E have been isolated from V. tricolor. Cyclotide-enriched preparations (including hot-water decoctions) reduce T-cell proliferation and macrophage cytokine output in vitro, of interest for inflammatory bowel disease.
Pharmacological Actions
Anti-inflammatory / immunomodulatory for chronic skin conditions - eczema, psoriasis, itching and scabs (traditional, supported by cyclotide research) - cyclotide-enriched V. tricolor preparations suppress T-cell proliferation and pro-inflammatory cytokine secretion in vitro; Soothes irritated skin (demulcent and anti-inflammatory)
Cytotoxic / antiproliferative against cancer cell lines in vitro (cyclotides vitri A, varv A and varv E)
Soothes irritated skin (demulcent and anti-inflammatory); Traditional demulcent / expectorant for cough, bronchitis and chest inflammation
Traditional demulcent / expectorant for cough, bronchitis and chest inflammation
Anti-inflammatory / immunomodulatory for chronic skin conditions - eczema, psoriasis, itching and scabs (traditional, supported by cyclotide research) - cyclotide-enriched V. tricolor preparations suppress T-cell proliferation and pro-inflammatory cytokine secretion in vitro
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antifungal action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Traditional demulcent / expectorant for cough, bronchitis and chest inflammation
inferred from anticancer action
Traditional demulcent / expectorant for cough, bronchitis and chest inflammation
Anti-inflammatory / immunomodulatory for chronic skin conditions - eczema, psoriasis, itching and scabs (traditional, supported by cyclotide research) - cyclotide-enriched V. tricolor preparations suppress T-cell proliferation and pro-inflammatory cytokine secretion in vitro
inferred from immunomodulator action
Traditional demulcent / expectorant for cough, bronchitis and chest inflammation
Anti-inflammatory / immunomodulatory for chronic skin conditions - eczema, psoriasis, itching and scabs (traditional, supported by cyclotide research) - cyclotide-enriched V. tricolor preparations suppress T-cell proliferation and pro-inflammatory cytokine secretion in vitro
inferred from expectorant action
Soothes irritated skin (demulcent and anti-inflammatory)
Safety, Cautions & Contraindications
Eucalyptus globulus essential oil is highly concentrated and rich in the monoterpene 1,8-cineole; it should never be applied undiluted to the skin or ingested outside of standardized pharmaceutical preparations. Improper use can cause irritation, nausea, dizziness, or neurological symptoms, and inhalation at high concentrations may provoke respiratory distress, particularly in infants, young children, or individuals with asthma or other airway sensitivities. For this reason, essential oil use is generally discouraged in children and during pregnancy unless under professional guidance. Preparations such as leaf-infused oils or external applications using whole plant material are considerably milder, but they should still be used with care and an understanding that different preparation methods carry different levels of risk.
Duke (2002) provides clinical evidence (score 2) for eucalyptus as an expectorant and topical hyperemic (rubefacient), consistent with Commission E approval. Clinical evidence also supports its use in asthma, bronchitis, and catarrh. The essential oil (primarily 1,8-cineole) is the active constituent. Therapeutic use as steam inhalation is well-established. Internal use of the essential oil at high doses is contraindicated due to toxicity; even small amounts (3.5 ml) can be fatal in children. Contraindicated for inflammatory diseases of the gastrointestinal tract or bile ducts (Duke, 2002).
Regarded as safe in customary traditional use; because the extract suppresses immune-cell activity, there is a theoretical caution when taking immunosuppressant medicines.
Contains salicylates, so use caution if you are salicylate-sensitive; safety in pregnancy and breastfeeding is not established.
External Ids
Botanical Description
Large, fast-growing evergreen tree with distinctive two-stage leaves: rounded, silvery-blue juvenile leaves borne in opposite pairs, giving way to narrow, sickle-shaped, aromatic, dark green mature leaves as the tree ages. Small, cream-white, fluffy flowers with numerous stamens are borne singly or in small clusters, followed by a woody, cup-shaped seed capsule ('gum nut').[12]
Small, low-growing annual or short-lived perennial herb with oval to lance-shaped, scalloped leaves and large, leaf-like stipules. The distinctive flowers are tricoloured - purple, yellow and white in varying combinations - with five petals, the lower petal often marked with dark veining (a 'face' pattern), giving rise to the name 'heartsease'.[9]
Habitat
Native to south-eastern Australia and Tasmania; widely planted worldwide in warm-temperate and Mediterranean climates for timber, essential oil production and as an ornamental/windbreak tree.
Grows in grassland, cultivated ground, gardens and waste places on a wide range of soils; native to Europe and widely naturalised elsewhere as a common garden and wild plant.[9]
Harvesting
Mature leaves are picked or pruned year-round and used fresh, dried, or steam-distilled for essential oil, which is the main commercial and medicinal form.
The flowering aerial parts are cut in summer while in flower and dried in a warm, shaded, airy place.[9]
Traditional Uses
Eucalyptus leaf has a long Australian Aboriginal and, after global spread, worldwide tradition as a respiratory remedy - inhaled as steam or applied as chest rubs for colds, coughs, bronchitis and catarrh - and as a topical antiseptic and rubefacient for minor wounds and muscular aches.[12]
Heartsease has a long European folk history as a soothing remedy for skin conditions such as eczema and itching, and as a traditional demulcent and expectorant for coughs and chest complaints; this traditional skin-supportive use is now linked to immunomodulatory cyclic peptides (cyclotides) unique to the Viola genus.[9]
Preparations
A few drops of essential oil, or fresh/dried leaf, added to hot water and the vapour inhaled for respiratory congestion; the classic and best-established use.
Diluted essential oil in a carrier oil or standardised ointment applied to the chest and back for coughs and colds.
Comminuted dried leaf infused in 150 ml boiling water, 1.5-3 g up to four times daily (daily dose 4.5-12 g) for oral use per the EU herbal monograph. Educational reference only, not a prescription.
Dried flowering herb infused in hot water, taken internally for cough or used as a cooled compress for skin irritation.
Dosage
The EU herbal monograph on eucalyptus LEAF gives, for inhalation, 3 g of the comminuted leaf in boiling water up to 3 times daily (daily dose 3-9 g), and for oral use 1.5-3 g in 150 mL as an infusion up to 4 times daily (daily dose 4.5-12 g), in adolescents, adults and elderly. Use is CONTRAINDICATED in children under 30 months, and not recommended under 12 years. The essential oil is a separate herbal substance with its own monograph and its own posology - it is never taken internally or applied undiluted to skin on the strength of these leaf figures. Educational reference only, not a prescription.
The EU herbal monograph gives, for oral use in adults and elderly, 3 g of the comminuted herb as an infusion 1-3 times daily. For cutaneous use, 5-20 g/L as an infusion applied as a wet dressing 2-3 times daily, or 5-10 g/L as a bath additive (1 litre of infusion per bath). Contraindicated in hypersensitivity to salicylates, and cutaneously on open wounds or large areas of damaged skin. Oral use not recommended under 18 years. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Čmiková, N., Galovičová, L., Schwarzová, M., Vukic, M.D. et al (2023) 'Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil', Plants (Basel), 12(5), pp. 1076. doi:10.3390/plants12051076 Preclinical
https://doi.org/10.3390/plants12051076 - Elangovan, S. and Mudgil, P (2023) 'Antibacterial Properties of Eucalyptus globulus Essential Oil against MRSA: A Systematic Review', Antibiotics (Basel), 12(3), pp. 474. doi:10.3390/antibiotics12030474 Meta-analysis / review
https://doi.org/10.3390/antibiotics12030474 - Zonfrillo, M., Andreola, F., Krasnowska, E.K., Sferrazza, G. et al (2022) 'Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages', Molecules, 27(11), pp. 3488. doi:10.3390/molecules27113488 Preclinical
https://doi.org/10.3390/molecules27113488 - Arooj, B., Asghar, S., Saleem, M., Khalid, S.H., Asif, M., Chohan, T., Khan, I.U., Zubair, H.M. and Yaseen, H.S (2023) 'Anti-inflammatory mechanisms of eucalyptol rich Eucalyptus globulus essential oil alone and in combination with flurbiprofen', Inflammopharmacology, 31(4), pp. 1849-1862. doi:10.1007/s10787-023-01237-6 Preclinical
https://doi.org/10.1007/s10787-023-01237-6 - Assaggaf, H.M., Naceiri Mrabti, H., Rajab, B.S., Attar, A.A., Hamed, M., Sheikh, R.A., Omari, N.E., Menyiy, N.E., Belmehdi, O., Mahmud, S., Alshahrani, M.M., Park, M.N., Kim, B., Zengin, G. and Bouyahya, A (2022) 'Singular and Combined Effects of Essential Oil and Honey of Eucalyptus globulus on Anti-Inflammatory, Antioxidant, Dermatoprotective, and Antimicrobial Properties: In Vitro and In Vivo Findings', Molecules, 27(16), pp. 5121. doi:10.3390/molecules27165121 Preclinical
https://doi.org/10.3390/molecules27165121 - Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J. and Wink, M (2010) 'Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens', Phytomedicine, 17(13), pp. 1061-1066. doi:10.1016/j.phymed.2010.06.018 Preclinical
https://doi.org/10.1016/j.phymed.2010.06.018 - Luis, A., Neiva, D., Pereira, H., Gominho, J., Domingues, F. and Duarte, A.P (2014) 'Stumps of Eucalyptus globulus as a source of antioxidant and antimicrobial polyphenols', Molecules, 19(10), pp. 16428-16446. doi:10.3390/molecules191016428 Preclinical
https://doi.org/10.3390/molecules191016428 - Merghni, A., Noumi, E., Hadded, O., Dridi, N., Panwar, H., Ceylan, O., Mastouri, M. and Snoussi, M (2018) 'Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains', Microbial Pathogenesis, 118, pp. 74-80. doi:10.1016/j.micpath.2018.03.006 Preclinical
https://doi.org/10.1016/j.micpath.2018.03.006 - Mousa, A.A., Elweza, A.E., Elbaz, H.T., Tahoun, E.A.E., Shoghy, K.M., Elsayed, I. and Hassan, E.B (2019) 'Eucalyptus Globulus protects against diclofenac sodium induced hepatorenal and testicular toxicity in male rats', Journal of Traditional and Complementary Medicine, 10(6), pp. 521-528. doi:10.1016/j.jtcme.2019.11.002 Preclinical
https://doi.org/10.1016/j.jtcme.2019.11.002 - Mota, V.S., Turrini, R.N.T. and Poveda, V.B (2015) 'Antimicrobial activity of Eucalyptus globulus oil, xylitol and papain: a pilot study', Revista da Escola de Enfermagem da USP, 49(2), pp. 216-220. doi:10.1590/S0080-623420150000200005 Preclinical
https://doi.org/10.1590/S0080-623420150000200005 - Nguyen, H.T.T., Miyamoto, A., Nguyen, H.T., Pham, H.T., Hoang, H.T., Tong, N.T.M., Truong, L.T.N. and Nguyen, H.T.T (2023) 'Antibacterial effects of essential oils from Cinnamomum cassia bark and Eucalyptus globulus leaves - the involvements of major constituents', PLoS One, 18(7), pp. e0288787. doi:10.1371/journal.pone.0288787 Preclinical
https://doi.org/10.1371/journal.pone.0288787 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Eucalyptus globulus Labill., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf - Sadlon, A.E. and Lamson, D.W (2010) 'Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices', 15(1), pp. 33--47. Preclinical
https://scholar.google.com/scholar?q=Immune-modifying%20and%20antimicrobial%20effects%20of%20Eucalyptus%20oil%20and%20simple%20inhalation%20devices - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Retzl, B., Zimmermann-Klemd, A.M., Winker, M., Nicolay, S., Grundemann, C. and Gruber, C.W (2023) 'Exploring Immune Modulatory Effects of Cyclotide-Enriched Viola tricolor Preparations', Planta Medica, 89(15), pp. 1493--1504. doi:10.1055/a-2173-8627 Preclinical
https://doi.org/10.1055/a-2173-8627 - Harati, E., Bahrami, M., Razavi, A., Kamalinejad, M. and others (2018) 'Effects of Viola tricolor Flower Hydroethanolic Extract on Lung Inflammation in a Mouse Model of Chronic Asthma', Iranian Journal of Allergy, Asthma, and Immunology, 17(5), pp. 409-417. doi:10.18502/ijaai.v17i5.299 Preclinical
https://doi.org/10.18502/ijaai.v17i5.299 - Sadeghnia, H.R., Ghorbani Hesari, T., Mortazavian, S.M., Mousavi, S.H. and others (2014) 'Viola tricolor induces apoptosis in cancer cells and exhibits antiangiogenic activity on chicken chorioallantoic membrane', BioMed Research International, 2014, pp. 625792. doi:10.1155/2014/625792 Preclinical
https://doi.org/10.1155/2014/625792 - Mousavi, S.H., Naghizade, B., Pourgonabadi, S. and Ghorbani, A (2016) 'Protective effect of Viola tricolor and Viola odorata extracts on serum/glucose deprivation-induced neurotoxicity: role of reactive oxygen species', Avicenna Journal of Phytomedicine, 6(4), pp. 434-441. Preclinical
https://scholar.google.com/scholar?q=Protective%20effect%20of%20Viola%20tricolor%20and%20Viola%20odorata%20extracts%20on%20serum/glucose%20deprivation-induced%20neurotoxicity%3A%20role%20of%20reactive%20oxygen%20species - Witkowska-Banaszczak, E., Bylka, W., Matlawska, I., Goslinska, O. and Muszynski, Z (2005) 'Antimicrobial activity of Viola tricolor herb', Fitoterapia, 76(5), pp. 458-461. doi:10.1016/j.fitote.2005.03.005 Preclinical
https://doi.org/10.1016/j.fitote.2005.03.005 - Baradaran Rahimi, V., Askari, V.R., Hosseini, M., Yousefsani, B.S. and Sadeghnia, H.R (2019) 'Anticonvulsant Activity of Viola tricolor against Seizures Induced by Pentylenetetrazol and Maximal Electroshock in Mice', Iranian Journal of Medical Sciences, 44(3), pp. 220-226. Preclinical
https://scholar.google.com/scholar?q=Anticonvulsant%20Activity%20of%20Viola%20tricolor%20against%20Seizures%20Induced%20by%20Pentylenetetrazol%20and%20Maximal%20Electroshock%20in%20Mice - Piana, M., Silva, M.A., Trevisan, G., de Brum, T.F. and others (2013) 'Antiinflammatory effects of Viola tricolor gel in a model of sunburn in rats and the gel stability study', Journal of Ethnopharmacology, 150(2), pp. 458-465. doi:10.1016/j.jep.2013.08.040 Preclinical
https://doi.org/10.1016/j.jep.2013.08.040 - Han, B.Y., Wang, Z.L., Li, J., Jin, Q. and others (2023) 'A highly selective C-rhamnosyltransferase from Viola tricolor and insights into its mechanisms', Acta Pharmaceutica Sinica B, 13(8), pp. 3535-3544. doi:10.1016/j.apsb.2023.05.011 Preclinical
https://doi.org/10.1016/j.apsb.2023.05.011 - Hellinger, R., Koehbach, J., Fedchuk, H., Sauer, B., Huber, R., Gruber, C.W. and Grundemann, C (2013) 'Immunosuppressive activity of an aqueous Viola tricolor herbal extract', Journal of Ethnopharmacology, pp. 2013. doi:10.1016/j.jep.2013.10.044 Traditional / reference
https://doi.org/10.1016/j.jep.2013.10.044 - Kirichenko, T.V., Sobenin, I.A., Nikolic, D., Rizzo, M. and Orekhov, A.N (2015) 'Anti-cytokine therapy for prevention of atherosclerosis', Phytomedicine, 23(11), pp. 1198-1210. doi:10.1016/j.phymed.2015.12.002 Clinical study
https://doi.org/10.1016/j.phymed.2015.12.002 - Conzelmann, C., Muratspahic, E., Tomasevic, N., Munch, J. and Gruber, C.W (2022) 'Inhibition of HIV-1 by Cyclotide-Enriched Extracts of Viola tricolor', Frontiers in Pharmacology, 13, pp. 888961. doi:10.3389/fphar.2022.888961 Preclinical
https://doi.org/10.3389/fphar.2022.888961 - Maraschio, A., Wulhfard, K. and Monsellato, L (2023) 'Case study of clinical improvement of atopic dermatitis in a patient treated with herbal-based parapharmaceuticals', Journal of Complementary & Integrative Medicine, 20(2), pp. 504-511. doi:10.1515/jcim-2023-0005 Clinical study
https://doi.org/10.1515/jcim-2023-0005 - Svangard, E. and Goransson, U. and Hocaoglu, Z. and Gullbo, J. and Larsson, R. and Claeson, P. and Bohlin, L (2004) 'Cytotoxic cyclotides from Viola tricolor', Journal of Natural Products, 67(2), pp. 144--147. doi:10.1021/np030101l Preclinical
https://doi.org/10.1021/np030101l - European Medicines Agency (HMPC) (2010) 'Community herbal monograph on Viola tricolor L. and/or subspecies Viola arvensis Murray (Gaud) and Viola vulgaris Koch (Oborny), herba cum flore'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-viola-tricolor-l_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-viola-tricolor-l_en.pdf
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.